Charles River Laboratories International, Inc. (CRL)
288.24
-3.26
(-1.12%)
USD |
NYSE |
Aug 31, 16:00
288.67
+0.43
(+0.15%)
Pre-Market: 20:00
Charles River Laboratories International Cash from Operations (Annual) : 737.65M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 737.65M |
| December 31, 2024 | 734.58M |
| December 31, 2023 | 683.90M |
| December 31, 2022 | 619.64M |
| December 31, 2021 | 760.80M |
| December 31, 2020 | 546.58M |
| December 31, 2019 | 480.94M |
| December 31, 2018 | 441.14M |
| December 31, 2017 | 318.07M |
| December 31, 2016 | 300.38M |
| December 31, 2015 | 288.23M |
| December 31, 2014 | 252.13M |
| December 31, 2013 | 209.04M |
| December 31, 2012 | 208.01M |
| December 31, 2011 | 206.84M |
| Date | Value |
|---|---|
| December 31, 2010 | 168.24M |
| December 31, 2009 | 217.44M |
| December 31, 2008 | 282.24M |
| December 31, 2007 | 288.42M |
| December 31, 2006 | 175.97M |
| December 31, 2005 | 216.78M |
| December 31, 2004 | 184.83M |
| December 31, 2003 | 123.77M |
| December 31, 2002 | 133.66M |
| December 31, 2001 | 71.30M |
| December 31, 2000 | 33.77M |
| December 31, 1999 | |
| December 31, 1998 | 37.38M |
| December 31, 1997 | 24.32M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| IQVIA Holdings, Inc. | 2.654B |
| Medpace Holdings, Inc. | 713.22M |
| Fortrea Holdings, Inc. | 113.50M |
| Avantor, Inc. | 623.80M |
| Champions Oncology, Inc. | -4.472M |